换一批Different impact of excision repair cross-complementation group 1 on survival in male and female patients with inoperable non-small-cell lung cancer treated with carboplatin and gemcitabine.
第一作者：
Bente,Holm
第一单位：
Department of Oncology, Herlev Hospital, DK-2730 Herlev, Denmark. bholm@dadlnet.dk
作者：
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);DNA结合蛋白质类(DNA-Binding Proteins);脱氧胞苷(Deoxycytidine);内切核酸酶类(Endonucleases);女(雌)性(Female);人类(Humans);免疫组织化学(Immunohistochemistry);Kaplan-Meiers评估(Kaplan-Meier Estimate);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);比例危险度模型(Proportional Hazards Models);回顾性研究(Retrospective Studies);性别因素(Sex Factors);治疗结果(Treatment Outcome)
DOI
10.1200/JCO.2008.18.8631
PMID
19667277
发布时间
2022-12-07
- 浏览16
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
